Tokyo, June 19 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000061950) titled 'Improving CKD Diagnosis and Treatment Rates Through Support Programs in Primary Care Settings: A Scientific Approach to Investigating a Multi-Channel Support Program to Improve CKD Diagnosis and Management in Primary Care. (Phase 1)' on June 18.
Study Type:
Observational
Primary Sponsor:
Institute - Nippon Boehringer Ingelheim Co., Ltd.
Condition:
Condition - Chronic kidney disease (CKD)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the level of understanding regarding CKD among primary care physicians, including disease knowledge, diagnostic definitions, diagnostic methods, and pharmacotherapy interventions through a questionnaire survey.
Basic objectives2 - Others
Eligibility:
Age-lower limit - Not applicable
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - -PCPs practicing at a clinic in Japan.
-PCPs registered on the nationwide M3 platform.
-PCPs having opportunities to diagnose and treat patients with CKD.
Key exclusion criteria - PCPs self-reporting their primary specialty in any fields other than the designated internal medicine subspecialties, which include general internal medicine, cardiology, gastroenterology, respiratory medicine, diabetes/endocrinology and metabolism, rheumatology/collagen disease, and allergy.
Target Size - 200
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 05 Month 08 Day
Date of IRB - 2026 Year 05 Month 20 Day
Anticipated trial start date - 2026 Year 06 Month 18 Day
Last follow-up date - 2028 Year 04 Month 30 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000070890
Disclaimer: Curated by HT Syndication.
